Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE
Public ClinicalTrials.gov record NCT04293458. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Single-Arm Study of the Efficacy of EsoGuard(TM) on Samples Collected Using EsoCheck(TM) Versus Esophagogastroduodenoscopy for the Diagnosis of Barrett's Esophagus in an At-Risk Screening Population
Study identification
- NCT ID
- NCT04293458
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Lucid Diagnostics, Inc.
- Industry
- Enrollment
- 145 participants
Conditions and interventions
Conditions
Interventions
- EsoGuard Device
Device
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- Male
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 27, 2020
- Primary completion
- Aug 21, 2022
- Completion
- Aug 21, 2022
- Last update posted
- Jan 24, 2023
2020 – 2022
United States locations
- U.S. sites
- 24
- U.S. states
- 19
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lucid Investigative Site | Orange | California | 92868 | — |
| Lucid Investigative Site | Englewood | Colorado | 80113 | — |
| Lucid Investigative Site | Naples | Florida | 34102 | — |
| Lucid Investigative Site | Palm Harbor | Florida | 34684 | — |
| Lucid Investigative Site | Macon | Georgia | 31201 | — |
| Lucid Investigative Site | Idaho Falls | Idaho | 83404 | — |
| Lucid Investigative Site | Rockford | Illinois | 61107 | — |
| Lucid Investigative Site | New Orleans | Louisiana | 70112 | — |
| Lucid Investigative Site | Shreveport | Louisiana | 71105 | — |
| Lucid Investigative Site | Wyoming | Michigan | 49519 | — |
| Lucid Investigative Site | Flowood | Mississippi | 39232 | — |
| Lucid Investigative Site | Omaha | Nebraska | 68124 | — |
| Lucid Investigative Site | New York | New York | 10016 | — |
| Lucid Investigative Site | Rochester | New York | 14620 | — |
| Lucid Investigative Site | Chapel Hill | North Carolina | 27599 | — |
| Lucid Investigative Site | Oklahoma City | Oklahoma | 73102 | — |
| Lucid Investigative Site | Philadelphia | Pennsylvania | 19107 | — |
| Lucid Investigative Site | Greenville | South Carolina | 29615 | — |
| Lucid Investigative Site | Knoxville | Tennessee | 37909 | — |
| Lucid Investigative Site | Nashville | Tennessee | 37212 | — |
| Lucid Investigative Site | Houston | Texas | 77030 | — |
| Lucid Investigative Site | Salt Lake City | Utah | 84132 | — |
| Lucid Investigative Site | Richmond | Virginia | 23249 | — |
| Lucid Investigative Site | Richmond | Virginia | 23298 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04293458, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 24, 2023 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04293458 live on ClinicalTrials.gov.